NCT05624268Phase 3Completed

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Study sponsor: COMPASS Pathways

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-28Actual
Enrollment · participants258Actual
Source updated2026-08-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 255 participants (planned). After: 258 participants (actual).

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview